Insider Trading & Ownership - GOEL DAVID E.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for GOEL DAVID E.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-11-09
Purchase
2023-11-09
4:35 pm
Aura Biosciences Inc.AURAMatrix Capital Management Company LP
GOEL DAVID E.
10% Owner
1,560,000$9$14,040,0006,922,870
(Indirect)
View
2023-06-20
Purchase
2023-06-20
4:30 pm
Zentalis Pharmaceuticals Inc.ZNTLMatrix Capital Management Company LP
GOEL DAVID E.
10% Owner
4,760,000$22.66$107,861,60013,959,973
(Indirect)
View
2022-12-05
Purchase
2022-12-07
4:30 pm
Aura Biosciences Inc.AURAMatrix Capital Management Company LP
GOEL DAVID E.
10% Owner
1,250,000$12$15,000,0005,362,870
(Indirect)
View
2021-11-02
Purchase
2021-11-04
4:44 pm
Aura Biosciences Inc.AURAMatrix Capital Management Company LP
GOEL DAVID E.
10% Owner
1,785,000$14$24,990,0004,112,870
(Indirect)
View
2021-03-08
Sale
2021-03-10
7:45 pm
Adaptive Biotechnologies CorpADPTGOEL DAVID E.
Matrix Capital Management Company LP
See Remarks
806,000$39.99$32,228,82712,310,594
(Indirect
Direct)
View
2020-07-20
Sale
2020-07-22
4:15 pm
Adaptive Biotechnologies CorpADPTGOEL DAVID E.
Matrix Capital Management Company LP
See Remarks
10% Owner
2,000,000$40$80,000,00013,115,090
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-07-01
Conversion
2024-07-03
4:45 pm
N/A
N/A
ALUMIS INC.AyurMaya Capital Management Company LP
GOEL DAVID E.
See Remarks
10% Owner
46,228,371$010,645,966
(Indirect)
View
2024-07-01
Option Award
2024-07-03
4:45 pm
N/A
N/A
ALUMIS INC.AyurMaya Capital Management Company LP
GOEL DAVID E.
See Remarks
10% Owner
2,500,000$1610,645,966
(Indirect)
View

Ownership
2024-06-27
6:42 pm
N/A
N/A
ALUMIS INC.AyurMaya Capital Management Company LP
GOEL DAVID E.
See Remarks
10% Owner
0$08,145,966
(Indirect)
View
2023-05-09
Conversion
2023-05-11
4:10 pm
N/A
N/A
ACELYRIN Inc.SLRNAyurMaya Capital Management Company LP
GOEL DAVID E.
See Remarks
18,669,470$09,334,735
(Indirect)
View

Ownership
2023-05-04
7:00 pm
N/A
N/A
ACELYRIN Inc.SLRNAyurMaya Capital Management Company LP
GOEL DAVID E.
See Remarks
10% Owner
0$09,334,735
(Indirect)
View

Ownership
2022-06-03
10:54 am
N/A
N/A
Zentalis Pharmaceuticals Inc.ZNTLMatrix Capital Management Company LP
GOEL DAVID E.
10% Owner
0$09,199,973
(Indirect)
View
2021-11-02
Conversion
2021-11-04
4:44 pm
N/A
N/A
Aura Biosciences Inc.AURAMatrix Capital Management Company LP
GOEL DAVID E.
10% Owner
2,327,870$04,112,870
(Indirect)
View

Ownership
2021-10-28
8:39 pm
N/A
N/A
Aura Biosciences Inc.AURAMatrix Capital Management Company LP
GOEL DAVID E.
10% Owner
0$02,327,870
(Indirect)
View
2021-02-15
Option Award
2021-02-17
9:40 pm
N/A
2031-02-15
Adaptive Biotechnologies CorpADPTGOEL DAVID E.
Director
5,263$05,263
(Direct)
View
2020-02-13
Option Award
2020-05-11
4:15 pm
N/A
2030-02-13
Adaptive Biotechnologies CorpADPTGOEL DAVID E.
Director
10% Owner
8,888$08,888
(Direct)
View

Ownership
2020-04-03
6:00 pm
N/A
N/A
Zentalis Pharmaceuticals LLCZNTLGOEL DAVID E.
Matrix Capital Management Company LP
Director
10% Owner
0$03,821,739
(Indirect)
View
2020-01-24
Conversion
2020-01-28
4:15 pm
N/A
N/A
Adaptive Biotechnologies CorpADPTGOEL DAVID E.
Matrix Capital Management Company LP
See Remarks
10% Owner
2,217,101$26.515,115,090
(Indirect)
View